Generalized anxiety disorder with comorbid depression: case report
Moscow research Institute of psychiatry of the "Federal medical research center for psychiatry and addiction" Ministry of health of Russia
Summary: . This publication describes the clinical case of generalized anxiety disorder with comorbid depression, the dynamics of the development of the underlying disease and the accession of comorbid disorders, discusses the difficulties of diagnosis, differential diagnostic and therapeutic possibilities. This clinical case reflect the actual psychiatric practice, when patients suffering from generalized anxiety disorder, fall within the field of view of the psychiatrist at the time of the development of depressive symptoms, which covers and hides the symptoms of anxiety disorder, and core symptoms of generalized anxiety remains without attention and treatment. A significant prevalence of generalized anxiety disorder and the frequency of the accession of depression defines a significant number of such cases in practice, and calls attention to the accurate diagnosis to ensure effective treatment for prevention of patient’s social impairment.
1. Mosolov C.N. Trevozhny`e i depressivny`e rasstrojstva: komorbidnost` i terapiya. M.: Artinfo Pablishing. – 2007. – C. 63.
2. Chaxava V.O., Less Yu.E`. Kliniko-e`pidemiologicheskoe issledovanie generalizovannogo trevozhnogo rasstrojstva // Social`naya i klinicheskaya psixiatriya. – 2008. – № 1, t. 18. – C. 38–41.
3. Angst J. Comorbidity of anxiety, phobia, compulsion and depression // Int J Clin Psychopharmacol. – 1993. – № 8 (Suppl. 1). – P. 21–25.
4. Brawman-Mintzer O., Ludiard R. B., Emmanuel N. et al. Psychiatric comorbidity in patients with generalized anxiety disorder // Am J Psychiatry. – 1993. – No 150. – P. 1216–1218.
5. Vrown T.A., Barlow D.H. Comorbidity among anxiety disorders: implications for treatment and DSM-IV // J Consult Clin Psychol. – 1992. – No 60. – P. 835–855.
6. Brown T.A., Barlow D.H., Liebowitz M.R. The empirical basis of generalized anxiety disorder // Am J Psychiatry. – 1994. – No 151. – P. 1272–1280.
7. Kessler R.C., McGonagle K.A., Zhao S. et al. Lifetime and 12-montth prevalence of DSM-III-R psychiatric disorders in United States: results from the National Comorbidity Survey // Arch Gen Psychiatry. – 1994. – No 51. – P. 8–19.
8. Kessler R.C., Keller M.B., Wittchen H.U. The epidemiology of generalized anxiety disorder // Psychiatr Clin North Fm. – 2000. – No 24. – P. 19–24.
9. Rouillon F., Chignon J.M. Psychiatric comorbidity of anxiety disorders in the year 2000: Controversies and perspectives / Costa-e-Silva J.A. (ed.) // Proceeding of the meeting held in Paris 9, June 1992. – P. 26–34.
10. Sanderson W.C., Barlow D.H. A description of patients diagnosed with DSM-III-R generalized anxiety disorder // J Nerv Ment Dis. – 1990. – No 178. – P. 588–591.
11. Wittchen H.-U., Zhao S. et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey // Arch Gen Psychiatry. – 1994. – № 51. – P. 355–364.
12. Wittchen H.-U., Lieb R., Schuster P. et al. When is onset? investigations into early developmental stages of anxiety and depressive disorders // Rapoport J.L. (ed.) Childhood Onset of “Adult” Psychopathology: Clinical and Research Advances. – Washington, DC: American Psychiatric Press. – 1999. – P. 259–302.